Receptor 5-HT1A (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor 5-HT1A" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
low place
low place
low place
low place

acnp.org

  • Richard A. Glennon, Malgorzata Dukat, Richard B. Westkaemper, Serotonin Receptor Subtypes and Ligands [online], American College of Neuropsychopharmacology, 2000 [dostęp 2023-10-11].

doi.org

dx.doi.org

  • Paul R. Albert i inni, Constitutive Gi2-dependent Activation of Adenylyl Cyclase Type II by the 5-HT1A Receptor, „Journal of Biological Chemistry”, 274 (50), 1999, s. 35469–35474, DOI10.1074/jbc.274.50.35469, PMID10585418 [dostęp 2023-10-11] (ang.).
  • A. Fargin i inni, Effector Coupling Mechanisms of the Cloned 5-HT1A Receptor, „Journal of Biological Chemistry”, 264 (25), 1989, s. 14848–14852, DOI10.1016/S0021-9258(18)63778-0, PMID2549039 [dostęp 2023-10-11] (ang.).
  • Stanley L Lin i inni, Differential coupling of 5‐HT 1 receptors to G proteins of the G i family, „British Journal of Pharmacology”, 136 (7), 2002, s. 1072–1078, DOI10.1038/sj.bjp.0704809, PMID12145108, PMCIDPMC1573437 [dostęp 2023-10-11] (ang.).
  • Julián De Almeida, Guadalupe Mengod, Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment: Serotonin 1A receptor in primate prefrontal cortex, „Journal of Neurochemistry”, 107 (2), 2008, s. 488–496, DOI10.1111/j.1471-4159.2008.05649.x, PMID18761712 [dostęp 2023-10-11] (ang.).
  • Elena Akimova, Rupert Lanzenberger, Siegfried Kasper, The Serotonin-1A Receptor in Anxiety Disorders, „Biological Psychiatry”, 66 (7), 2009, s. 627–635, DOI10.1016/j.biopsych.2009.03.012, PMID19423077 [dostęp 2023-10-11] (ang.).
  • Miklos Toth, 5-HT1A receptor knockout mouse as a genetic model of anxiety, „European Journal of Pharmacology”, 463 (1-3), 2003, s. 177–184, DOI10.1016/S0014-2999(03)01280-9, PMID12600709 [dostęp 2023-10-11] (ang.).
  • Heike Kusserow i inni, Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors, „Molecular Brain Research”, 129 (1-2), 2004, s. 104–116, DOI10.1016/j.molbrainres.2004.06.028, PMID15469887 [dostęp 2023-10-11] (ang.).
  • C.T. Dourish, P.H. Hutson, G. Curzon, Pustative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphé nuclei, „Trends in Pharmacological Sciences”, 7, 1986, s. 212–214, DOI10.1016/0165-6147(86)90318-4 [dostęp 2023-10-11] (ang.).
  • Maura Boldrini i inni, Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides, „Journal of Psychiatric Research”, 42 (6), 2008, s. 433–442, DOI10.1016/j.jpsychires.2007.05.004, PMID17574270, PMCIDPMC2268626 [dostęp 2023-10-11] (ang.).
  • Jonathan Savitz, Irwin Lucki, Wayne C. Drevets, 5-HT1A receptor function in major depressive disorder, „Progress in Neurobiology”, 88 (1), 2009, s. 17–31, DOI10.1016/j.pneurobio.2009.01.009, PMID19428959, PMCIDPMC2736801 [dostęp 2023-10-11] (ang.).
  • Marie-Bernadette Assié i inni, F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity, „The International Journal of Neuropsychopharmacology”, 13 (10), 2010, s. 1285–1298, DOI10.1017/S1461145709991222, PMID20059805 [dostęp 2023-10-11] (ang.).
  • Franco Borsini i inni, Pharmacology of Flibanserin, „CNS Drug Reviews”, 8 (2), 2006, s. 117–142, DOI10.1111/j.1527-3458.2002.tb00219.x, PMID12177684, PMCIDPMC6741686 [dostęp 2023-10-11] (ang.).
  • Ethan B. Russo i inni, Agonistic Properties of Cannabidiol at 5-HT1a Receptors, „Neurochemical Research”, 30 (8), 2005, s. 1037–1043, DOI10.1007/s11064-005-6978-1, PMID16258853 [dostęp 2023-10-11] (ang.).
  • Leonardo B.M. Resstel i inni, 5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats, „British Journal of Pharmacology”, 156 (1), 2009, s. 181–188, DOI10.1111/j.1476-5381.2008.00046.x, PMID19133999, PMCIDPMC2697769 [dostęp 2023-10-11] (ang.).
  • Karl Rickels i inni, Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled Trial, „Journal of Clinical Psychopharmacology”, 28 (2), 2008, s. 235–239, DOI10.1097/JCP.0b013e31816774de, PMID18344738 [dostęp 2023-10-11] (ang.).
  • Allan Fletcher i inni, Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist, „Behavioural Brain Research”, 73 (1-2), 1995, s. 337–353, DOI10.1016/0166-4328(96)00118-0, PMID8788530 [dostęp 2023-10-11] (ang.).
  • Antonio Drago, Diana De Ronchi, Alessandro Serretti, 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies, „The International Journal of Neuropsychopharmacology”, 11 (05), 2008, DOI10.1017/S1461145707008218, PMID18047755 [dostęp 2023-10-11] (ang.).

nih.gov

ncbi.nlm.nih.gov

  • Gene HTR1A 5-hydroxytryptamine receptor 1A [Homo sapiens (human)] [online], NCBI [dostęp 2023-10-11].
  • Paul R. Albert i inni, Constitutive Gi2-dependent Activation of Adenylyl Cyclase Type II by the 5-HT1A Receptor, „Journal of Biological Chemistry”, 274 (50), 1999, s. 35469–35474, DOI10.1074/jbc.274.50.35469, PMID10585418 [dostęp 2023-10-11] (ang.).
  • A. Fargin i inni, Effector Coupling Mechanisms of the Cloned 5-HT1A Receptor, „Journal of Biological Chemistry”, 264 (25), 1989, s. 14848–14852, DOI10.1016/S0021-9258(18)63778-0, PMID2549039 [dostęp 2023-10-11] (ang.).
  • Stanley L Lin i inni, Differential coupling of 5‐HT 1 receptors to G proteins of the G i family, „British Journal of Pharmacology”, 136 (7), 2002, s. 1072–1078, DOI10.1038/sj.bjp.0704809, PMID12145108, PMCIDPMC1573437 [dostęp 2023-10-11] (ang.).
  • H. Ito, C. Halldin, L. Farde, Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique, „Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine”, 40 (1), 1999, s. 102–109, PMID9935065 [dostęp 2023-10-11] (ang.).
  • Julián De Almeida, Guadalupe Mengod, Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment: Serotonin 1A receptor in primate prefrontal cortex, „Journal of Neurochemistry”, 107 (2), 2008, s. 488–496, DOI10.1111/j.1471-4159.2008.05649.x, PMID18761712 [dostęp 2023-10-11] (ang.).
  • Elena Akimova, Rupert Lanzenberger, Siegfried Kasper, The Serotonin-1A Receptor in Anxiety Disorders, „Biological Psychiatry”, 66 (7), 2009, s. 627–635, DOI10.1016/j.biopsych.2009.03.012, PMID19423077 [dostęp 2023-10-11] (ang.).
  • Miklos Toth, 5-HT1A receptor knockout mouse as a genetic model of anxiety, „European Journal of Pharmacology”, 463 (1-3), 2003, s. 177–184, DOI10.1016/S0014-2999(03)01280-9, PMID12600709 [dostęp 2023-10-11] (ang.).
  • Heike Kusserow i inni, Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors, „Molecular Brain Research”, 129 (1-2), 2004, s. 104–116, DOI10.1016/j.molbrainres.2004.06.028, PMID15469887 [dostęp 2023-10-11] (ang.).
  • Maura Boldrini i inni, Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides, „Journal of Psychiatric Research”, 42 (6), 2008, s. 433–442, DOI10.1016/j.jpsychires.2007.05.004, PMID17574270, PMCIDPMC2268626 [dostęp 2023-10-11] (ang.).
  • Jonathan Savitz, Irwin Lucki, Wayne C. Drevets, 5-HT1A receptor function in major depressive disorder, „Progress in Neurobiology”, 88 (1), 2009, s. 17–31, DOI10.1016/j.pneurobio.2009.01.009, PMID19428959, PMCIDPMC2736801 [dostęp 2023-10-11] (ang.).
  • Marie-Bernadette Assié i inni, F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity, „The International Journal of Neuropsychopharmacology”, 13 (10), 2010, s. 1285–1298, DOI10.1017/S1461145709991222, PMID20059805 [dostęp 2023-10-11] (ang.).
  • Franco Borsini i inni, Pharmacology of Flibanserin, „CNS Drug Reviews”, 8 (2), 2006, s. 117–142, DOI10.1111/j.1527-3458.2002.tb00219.x, PMID12177684, PMCIDPMC6741686 [dostęp 2023-10-11] (ang.).
  • Ethan B. Russo i inni, Agonistic Properties of Cannabidiol at 5-HT1a Receptors, „Neurochemical Research”, 30 (8), 2005, s. 1037–1043, DOI10.1007/s11064-005-6978-1, PMID16258853 [dostęp 2023-10-11] (ang.).
  • Leonardo B.M. Resstel i inni, 5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats, „British Journal of Pharmacology”, 156 (1), 2009, s. 181–188, DOI10.1111/j.1476-5381.2008.00046.x, PMID19133999, PMCIDPMC2697769 [dostęp 2023-10-11] (ang.).
  • Karl Rickels i inni, Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled Trial, „Journal of Clinical Psychopharmacology”, 28 (2), 2008, s. 235–239, DOI10.1097/JCP.0b013e31816774de, PMID18344738 [dostęp 2023-10-11] (ang.).
  • C.A. Fornal i inni, WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135, „The Journal of Pharmacology and Experimental Therapeutics”, 278 (2), 1996, s. 752–762, PMID8768728 [dostęp 2023-10-11] (ang.).
  • Allan Fletcher i inni, Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist, „Behavioural Brain Research”, 73 (1-2), 1995, s. 337–353, DOI10.1016/0166-4328(96)00118-0, PMID8788530 [dostęp 2023-10-11] (ang.).
  • Antonio Drago, Diana De Ronchi, Alessandro Serretti, 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies, „The International Journal of Neuropsychopharmacology”, 11 (05), 2008, DOI10.1017/S1461145707008218, PMID18047755 [dostęp 2023-10-11] (ang.).

psychopharmacologyinstitute.com